Drawing for DAVITRI

USPTO serial 79301062

DAVITRI

Reviewed by CopyMark Law Group

Reg. 7095253Status 700Registered
Filing date
Status date
Registration date
Jul 4, 2023
Examiner
BLOHM, LINDA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with DAVITRI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Apparatus for scientific and laboratory research, namely, time-lapse incubators for embryo culture and embryo assessment for couples undergoing in vitro fertilization and intracytoplasmic sperm injection; educational apparatus and simulators, namely, timelapse incubators for embryo culture and embryo assessment for couples undergoing in vitro fertilization and intracytoplasmic sperm injection; scientific apparatus and instruments, namely, time lapse incubators for automated in vitro fertilization, denudation, embryo culture and embryo/gamete screening; research apparatus and instruments, namely, benchtop incubators for embryo culture and monitoring; laboratory apparatus and instruments, namely, namely, laboratory pipettes, and microfluidic biochips for gamete denudation, fertilization, embryo development and image capture; biochips for research or scientific purposes; fermentation apparatus for laboratory use; integrated software packages, namely, downloadable computer software for use in laboratory automation, all the aforesaid goods for use in connection with In Vitro Fertilization and the field of clinical reproduction onlyACTIVE
010Substance analysis apparatus for medical use, namely, microscopes, benchtop incubators, for use in providing assisted reproductive medical care; pH analyzers; temperature analyzers; sensors used to analyze culture media for pregnancy and miscarriage likelihood; medical diagnostic apparatus for medical use, namely, machines for detecting embryo DNA, metabolites, and proteins; tools for medical diagnosis, namely, mass spectrometers for analyzing biomarkers and identifying metabolomic profiling, genetic blueprint, aneuploidy screening, genetic abnormalities screening for pregnancy and miscarriage likelihood, all the aforesaid services for use in connection with In Vitro Fertilization and the field of clinical reproduction onlyACTIVE
042Design and testing of new products for others; scientific and technological services, namely, scientific research, medical analysis, biological testing in the fields in-vitro fertilization and in the field of clinical reproduction; Development of testing methods, namely, development of testing specifications and procedures for the medical industry; Conducting clinical trials and clinical studies for others; Computer-aided design of molds, all the aforesaid services for use in connection with In Vitro Fertilization and the field of clinical reproduction onlyACTIVE
044In-vitro fertilization services; analysis of human tissues for medical treatment; medical analyses for the diagnosis and treatment of people; medical consultancy in the field of pregnancy; medical assistance; medical care; medical consultations; gynecological cytology services; medical examination for persons; medical information; medical analysis services; medical and health services related to DNA, genetics and genetic testing; sperm bank services; human fertility treatment services; pregnancy testing services; all the aforesaid products are intended for exclusive use in relation to in-vitro fertilization and in the field of clinical reproductionACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 31, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Oct 5, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB
Oct 4, 2023FIMPFINAL DISPOSITION PROCESSED
Oct 4, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 4, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 4, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 31, 2023TMBNTTAB RELEASE CASE TO TRADEMARKS
May 31, 2023OP.TOPPOSITION TERMINATED NO. 999999
May 31, 2023OP.DOPPOSITION DISMISSED NO. 999999
Dec 4, 2022RFNTREFUSAL PROCESSED BY IB
Nov 22, 2022CHPBPOST PUBLICATION AMENDMENT - ENTERED
Nov 21, 2022APETASSIGNED TO PETITION STAFF
Nov 8, 2022OP.IOPPOSITION INSTITUTED NO. 999999
Nov 7, 2022OPNSOPPOSITION NOTICE (IB REFUSAL) SENT TO IB
Nov 5, 2022OPNCOPPOSITION NOTICE (IB REFUSAL) CREATED
Nov 4, 2022EPPATEAS POST PUBLICATION AMENDMENT RECEIVED
Jun 21, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 7, 2022ETOFEXTENSION OF TIME TO OPPOSE RECEIVED
Jun 1, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 1, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
May 16, 2022GPNXNOTIFICATION PROCESSED BY IB
May 10, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 10, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 20, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 20, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 20, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 2, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2022XAECEXAMINER'S AMENDMENT ENTERED
Apr 1, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 1, 2022GNEAEXAMINERS AMENDMENT E-MAILED
Apr 1, 2022CNEAEXAMINERS AMENDMENT -WRITTEN
Oct 28, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Oct 28, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 28, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 9, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Oct 8, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 8, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 25, 2021RFNTREFUSAL PROCESSED BY IB
Apr 8, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 8, 2021RFRRREFUSAL PROCESSED BY MPU
Apr 6, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 5, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 3, 2021DOCKASSIGNED TO EXAMINER
Jan 6, 2021MAFRAPPLICATION FILING RECEIPT MAILED
Jan 2, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 31, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance